Harbor Investment Advisory LLC Reduces Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Harbor Investment Advisory LLC lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 15.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,704 shares of the financial services provider’s stock after selling 311 shares during the period. Harbor Investment Advisory LLC’s holdings in iShares Biotechnology ETF were worth $225,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of IBB. Hsbc Holdings PLC boosted its position in iShares Biotechnology ETF by 47.1% in the 2nd quarter. Hsbc Holdings PLC now owns 3,670 shares of the financial services provider’s stock worth $504,000 after purchasing an additional 1,175 shares in the last quarter. AE Wealth Management LLC lifted its position in shares of iShares Biotechnology ETF by 10.7% during the 2nd quarter. AE Wealth Management LLC now owns 2,034 shares of the financial services provider’s stock valued at $279,000 after buying an additional 196 shares in the last quarter. Bank of Montreal Can lifted its position in shares of iShares Biotechnology ETF by 2.6% during the 2nd quarter. Bank of Montreal Can now owns 36,198 shares of the financial services provider’s stock valued at $5,086,000 after buying an additional 920 shares in the last quarter. Prairie Wealth Advisors Inc. lifted its position in shares of iShares Biotechnology ETF by 6.0% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock valued at $242,000 after buying an additional 100 shares in the last quarter. Finally, Security National Bank of SO Dak lifted its position in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after buying an additional 75 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.1 %

Shares of NASDAQ:IBB opened at $136.29 on Thursday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The business’s 50 day moving average price is $136.00 and its 200-day moving average price is $141.81.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.